| C105351 | 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene | "MAP3K5 protein affects the reaction [1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene results in increased degradation of MCL1 protein]" | 19768117 |
| C105351 | 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene | "MAP3K5 protein affects the reaction [1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene results in increased phosphorylation of MAPK8 protein]" | 19768117 |
| C105351 | 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene | "MAP3K5 protein affects the susceptibility to 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene" | 19768117 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAP3K5 protein" | 25639565 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAP3K5 protein]" | 25639565 |
| C029141 | 2,2,5,7,8-pentamethyl-1-hydroxychroman | "2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of MAP3K5 mRNA" | 21920950 |
| C025946 | 3-methyladenine | 3-methyladenine affects the susceptibility to MAP3K5 protein | 20929985 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [MAP3K5 protein results in decreased phosphorylation of MTOR protein] | 20929985 |
| C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [MAP3K5 protein affects the localization of CYCS protein] | 20929985 |
| C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [MAP3K5 protein results in increased activity of CASP3 protein] | 20929985 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| C012606 | 4-vinyl-1-cyclohexene dioxide | 4-vinyl-1-cyclohexene dioxide results in increased expression of MAP3K5 mRNA | 23274565 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein]" | 20206247 |
| C556801 | 8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione | "8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein]" | 20946892 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of MAP3K5 mRNA | 21420995|2906747 |
| D000082 | Acetaminophen | Acetaminophen results in increased activity of MAP3K5 protein | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ACTG1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of AK5 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARIH1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARL4A mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARL5B mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARRDC5 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ASTN2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of BCL2L14 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of BTC mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CASKIN1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CCDC81 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CCL7 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CD3E mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CDS2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CHIL3 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CHIL4 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CHKA mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CLASP1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of COL3A1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of COPG1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CXCL5 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DLX4 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DNAH5 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DNAJB4 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DNAJB9 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DPP6 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of EEA1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of FOSL2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of FOS mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of GAB2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of GNAL mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of GZMM mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of HIST2H2BB mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of IFIT3 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of JUN mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of KDM3A mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of MAFF mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of MCL1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of MX2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of MYH3 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NAIP6 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NEDD9 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NIPAL2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NSMCE2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of OBP2A mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of OLFR1273-PS mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of OLFR1339 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of OLFR905 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PCDH11X mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PCDH7 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PDCL2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PDE4B mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PRRX1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PVR mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of RNF207 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of RTP1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SCT mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SLC25A2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SLFN3 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SPZ1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of STAT3 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SYF2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TMEM54 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TRP63 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TSC22D2 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TWSG1 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of USP31 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of USP6NL mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of WDFY3 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ZDHHC6 mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ZFAND2A mRNA] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein promotes the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK8 protein] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein promotes the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK9 protein] | 18700144 |
| D000082 | Acetaminophen | MAP3K5 protein results in increased susceptibility to Acetaminophen | 18700144 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | 18703135 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein] | 20083342 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] | 16449798 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | 18703135 |
| D000171 | Acrolein | Acrolein results in increased expression of MAP3K5 protein | 17196791 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of MAP3K5 protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of MAP3K5 mRNA | 27153756 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP3K5 protein] | 20181660 |
| C030419 | andrographolide | andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP3K5 protein] | 24814888 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of MAP3K5 mRNA | 24449571 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite affects the expression of MAP3K5 mRNA" | 17331233 |
| D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein] | 20206247 |
| D001280 | Atrazine | Atrazine results in decreased expression of MAP3K5 mRNA | 25929836 |
| C487081 | belinostat | belinostat results in decreased expression of MAP3K5 mRNA | 27188386 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of MAP3K5 mRNA | 20064835 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of MAP3K5 mRNA | 19770486 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAP3K5 mRNA" | 19150397 |
| D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MAP3K5 mRNA | 19619570 |
| D004958 | Estradiol | Estradiol results in increased expression of MAP3K5 mRNA | 19619570 |
| D004958 | Estradiol | [bisphenol A co-treated with Estradiol] results in decreased expression of MAP3K5 mRNA | 26496021 |
| C006780 | bisphenol A | [bisphenol A co-treated with Estradiol] results in decreased expression of MAP3K5 mRNA | 26496021 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of MAP3K5 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased expression of MAP3K5 mRNA | 25461909 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of MAP3K5 mRNA | 15336504 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of MAP3K5 mRNA | 17441966 |
| D019256 | Cadmium Chloride | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | 18703135 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased activity of MAP3K5 protein | 16337887 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of MAP3K5 protein | 18703135 |
| D019256 | Cadmium Chloride | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | 18703135 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of MAP3K5 protein | 18021293|1870313 |
| C034939 | cadmium sulfide | cadmium sulfide results in decreased expression of MAP3K5 mRNA | 27866839 |
| D002166 | Camptothecin | Camptothecin results in decreased expression of MAP3K5 mRNA | 17374387 |
| C459604 | candoxin | candoxin results in decreased expression of MAP3K5 mRNA | 16309724 |
| D002518 | Ceramides | Ceramides analog affects the phosphorylation of and results in increased activity of MAP3K5 protein | 18270325 |
| D017608 | Chromium Compounds | Chromium Compounds results in increased activity of MAP3K5 protein | 19406221 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion inhibits the reaction [TXN protein binds to MAP3K5 protein] | 19703554 |
| D002922 | Ciguatoxins | Ciguatoxins affects the expression of MAP3K5 mRNA | 18353800 |
| D003300 | Copper | [NSC 689534 binds to Copper] which results in decreased expression of MAP3K5 mRNA | 20971185 |
| D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of MAP3K5 mRNA | 18579281 |
| D003630 | Daunorubicin | Daunorubicin results in decreased expression of MAP3K5 mRNA | 17374387 |
| D003676 | Deferoxamine | Deferoxamine inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein] | 20206247 |
| C007262 | deoxynivalenol | AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP3K5 protein] | 20181660 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased phosphorylation of MAP3K5 protein | 20181660 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of MAP3K5 mRNA] | 27941970 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of MAP3K5 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of MAP3K5 mRNA | 19561079|2739243 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of MAP3K5 mRNA | 26924002 |
| D004041 | Dietary Fats | Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein] | 26522834 |
| D004041 | Dietary Fats | [Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein | 26522834 |
| D002117 | Calcitriol | [Calcitriol promotes the reaction [TXNIP protein binds to TRN protein]] which results in increased activity of MAP3K5 protein | 10843682 |
| D002117 | Calcitriol | Calcitriol results in increased activity of MAP3K5 protein | 10843682 |
| C024629 | dimethyl phthalate | dimethyl phthalate affects the expression of MAP3K5 mRNA | 26924002 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein] | 12370186 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide results in decreased activity of MAP3K5 protein | 12370186 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased phosphorylation of MAP3K5 protein | 21628959 |
| D004229 | Dithiothreitol | Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] | 18922898 |
| D007980 | Levodopa | Levodopa results in increased activity of MAP3K5 protein | 21815648 |
| D007980 | Levodopa | MAP3K5 protein affects the susceptibility to Levodopa | 21815648 |
| D007980 | Levodopa | MAP3K5 protein affects the susceptibility to [Levodopa results in increased activity of CASP3 protein] | 21815648 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of MAP3K5 protein | 25896364 |
| D004317 | Doxorubicin | PSMB10 protein inhibits the reaction [Doxorubicin results in increased expression of MAP3K5 protein] | 25896364 |
| D004317 | Doxorubicin | PSMB8 protein inhibits the reaction [Doxorubicin results in increased expression of MAP3K5 protein] | 25896364 |
| D004317 | Doxorubicin | PSMB9 protein inhibits the reaction [Doxorubicin results in increased expression of MAP3K5 protein] | 25896364 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of MAP3K5 mRNA" | 26539117 |
| C098320 | efavirenz | efavirenz metabolite results in increased phosphorylation of MAP3K5 protein | 21958719 |
| C098320 | efavirenz | efavirenz results in increased phosphorylation of MAP3K5 protein | 21958719 |
| C118739 | entinostat | entinostat results in increased expression of MAP3K5 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| D000431 | Ethanol | ALDH2 protein inhibits the reaction [Ethanol results in increased phosphorylation of MAP3K5 protein] | 19332462 |
| D000431 | Ethanol | Ethanol results in increased phosphorylation of MAP3K5 protein | 19332462 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in decreased expression of MAP3K5 mRNA | 23649840 |
| D005047 | Etoposide | Etoposide results in decreased expression of MAP3K5 mRNA | 17374387 |
| D005054 | Eugenol | Eugenol results in increased phosphorylation of MAP3K5 protein | 21628959 |
| D005557 | Formaldehyde | Formaldehyde results in decreased expression of MAP3K5 mRNA | 23416264 |
| C039281 | furan | furan results in increased expression of MAP3K5 mRNA | 26194646 |
| C546771 | gardiquimod | gardiquimod results in increased expression of MAP3K5 mRNA | 28003376 |
| C546771 | gardiquimod | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MAP3K5 mRNA] | 28003376 |
| C001277 | geldanamycin | geldanamycin results in increased expression of MAP3K5 mRNA | 26705709 |
| D005947 | Glucose | Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein] | 14505347 |
| D005947 | Glucose | Glucose results in increased expression of MAP3K5 protein | 16731828 |
| D005947 | Glucose | Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein | 16731828 |
| D005947 | Glucose | [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein | 26660634 |
| D005947 | Glucose | [[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein | 26660634 |
| D005947 | Glucose | Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein | 26660634 |
| D005947 | Glucose | CAT protein inhibits the reaction [Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein]] | 14505347 |
| D005947 | Glucose | [CAT protein promotes the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] inhibits the reaction [Glucose deficiency results in increased activity of and results in increased phosphorylation of MAPK8 protein] | 14505347 |
| D017313 | Fenretinide | Fenretinide results in increased expression of MAP3K5 mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of MAP3K5 protein | 15629441 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of MAP3K5 protein | 16157298 |
| C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of MAP3K5 mRNA | 21396975 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of MAP3K5 mRNA | 25613284 |
| C051890 | irinotecan | irinotecan metabolite results in decreased expression of MAP3K5 mRNA | 15956246 |
| C051890 | irinotecan | irinotecan results in decreased expression of MAP3K5 mRNA | 15956246 |
| D007545 | Isoproterenol | Isoproterenol results in decreased expression of MAP3K5 mRNA | 21335049 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of MAP3K5 mRNA | 27392435 |
| D007608 | Kainic Acid | Kainic Acid results in decreased expression of MAP3K5 mRNA | 17997037 |
| C072105 | KN 93 | KN 93 inhibits the reaction [Phenylephrine results in increased activity of MAP3K5 protein] | 15629441 |
| D008070 | Lipopolysaccharides | MAP3K5 protein results in increased susceptibility to Lipopolysaccharides | 21449566 |
| C018091 | maduramicin | maduramicin results in increased expression of MAP3K5 mRNA | 29128925 |
| D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAP3K5 mRNA | 21641980 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K5 mRNA | 26378955 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased activity of MAP3K5 protein | 16337887 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of MAP3K5 mRNA | 19010555 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of MAP3K5 mRNA | 23649840 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased expression of MAP3K5 mRNA | 25234470 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein | 20946892 |
| D015655 | 1-Methyl-4-phenylpyridinium | "8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein]" | 20946892 |
| C571715 | mito-carboxy proxyl | mito-carboxy proxyl inhibits the reaction [troglitazone results in increased activity of MAP3K5 protein] | 17975114 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of MAP3K5 mRNA | 26924002 |
| C583365 | N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide | "N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide results in increased expression of MAP3K5 mRNA" | 29244179 |
| C064769 | N-acetylsphingosine | N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein | 18270325 |
| C064769 | N-acetylsphingosine | TXNIP affects the reaction [N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein] | 18270325 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of MAP3K5 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of MAP3K5 mRNA" | 25554681 |
| C005273 | naringenin | naringenin results in increased expression of MAP3K5 protein | 27838343 |
| C498045 | NCX 4040 | Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] | 18922898 |
| C498045 | NCX 4040 | NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein] | 18922898 |
| C498045 | NCX 4040 | [NCX 4040 results in increased oxidation of TXN1 protein] inhibits the reaction [TXN1 protein binds to MAP3K5 protein] | 18922898 |
| C490266 | neoechinulin A | neoechinulin A inhibits the reaction [[APP protein binds to APP protein binds to APP protein] which results in increased phosphorylation of MAP3K5 protein] | 23261590 |
| C017557 | nickel subsulfide | MAP3K5 protein affects the susceptibility to nickel subsulfide | 20112989 |
| C017557 | nickel subsulfide | nickel subsulfide results in increased phosphorylation of and results in increased activity of MAP3K5 protein | 20112989 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of MAP3K5 mRNA | 22714537 |
| D009599 | Nitroprusside | GHRL protein inhibits the reaction [Nitroprusside results in increased phosphorylation of and results in increased activity of MAP3K5 protein] | 17543279 |
| D009599 | Nitroprusside | Nitroprusside results in increased phosphorylation of and results in increased activity of MAP3K5 protein | 17543279 |
| D009599 | Nitroprusside | Quercetin inhibits the reaction [GHRL protein inhibits the reaction [Nitroprusside results in increased expression of MAP3K5 protein]] | 17543279 |
| C047330 | N-methylisoindigotin | N-methylisoindigotin results in increased expression of MAP3K5 mRNA | 26887594 |
| C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in decreased expression of MAP3K5 mRNA | 20971185 |
| C464660 | obeticholic acid | obeticholic acid results in decreased expression of MAP3K5 mRNA | 27939613 |
| D017239 | Paclitaxel | MAP3K5 protein affects the reaction [Paclitaxel results in increased activity of CASP3 protein] | 10075725 |
| D017239 | Paclitaxel | MAP3K5 protein affects the reaction [Paclitaxel results in increased cleavage of PARP1 protein] | 10075725 |
| C016030 | pantogab | pantogab results in increased expression of MAP3K5 mRNA | 17379144 |
| D010269 | Paraquat | [Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein | 20929985 |
| D010269 | Paraquat | [Paraquat co-treated with MAP3K5 protein] results in increased expression of BECN1 protein | 20929985 |
| D010269 | Paraquat | Paraquat promotes the reaction [MAP3K5 protein results in increased phosphorylation of ERN1 protein] | 20929985 |
| D010269 | Paraquat | Paraquat results in increased phosphorylation of and results in increased activity of MAP3K5 protein | 19735704 |
| D010269 | Paraquat | salubrinal affects the susceptibility to [Paraquat co-treated with MAP3K5 protein] | 20929985 |
| D010269 | Paraquat | salubrinal inhibits the reaction [Paraquat results in increased phosphorylation of and results in increased activity of MAP3K5 protein] | 19735704 |
| D010269 | Paraquat | salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein] | 20929985 |
| D010269 | Paraquat | salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased expression of BECN1 protein] | 20929985 |
| D010269 | Paraquat | MAP3K5 protein results in increased susceptibility to Paraquat | 20929985 |
| D052638 | Particulate Matter | Particulate Matter results in decreased expression of MAP3K5 mRNA | 17450221 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of MAP3K5 mRNA | 24769257 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of MAP3K5 mRNA | 26300304 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of MAP3K5 mRNA | 19270015 |
| C013192 | phenylacetaldehyde | phenylacetaldehyde results in increased phosphorylation of MAP3K5 protein | 21628959 |
| D010656 | Phenylephrine | CAMK2D protein promotes the reaction [Phenylephrine results in increased activity of MAP3K5 protein] | 15629441 |
| D010656 | Phenylephrine | KN 93 inhibits the reaction [Phenylephrine results in increased activity of MAP3K5 protein] | 15629441 |
| D010656 | Phenylephrine | Phenylephrine results in increased activity of MAP3K5 protein | 15629441 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of MAP3K5 mRNA | 26272509 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone results in decreased activity of MAP3K5 protein | 15824197 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of MAP3K5 mRNA | 18445702 |
| D010936 | Plant Extracts | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein]" | 20206247 |
| D010936 | Plant Extracts | Ascorbic Acid inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein] | 20206247 |
| D010936 | Plant Extracts | Deferoxamine inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein] | 20206247 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of MAP3K5 mRNA | 23557933 |
| D010936 | Plant Extracts | Plant Extracts results in increased phosphorylation of MAP3K5 protein | 20206247 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in increased expression of MAP3K5 mRNA | 22714537 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in increased expression of MAP3K5 mRNA | 28903501 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of MAP3K5 mRNA | 24780913 |
| D047428 | Protein Kinase Inhibitors | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MAP3K5 mRNA] | 28003376 |
| D011794 | Quercetin | Acetylcysteine inhibits the reaction [Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein] | 20083342 |
| D011794 | Quercetin | Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein | 20083342 |
| D011794 | Quercetin | Quercetin inhibits the reaction [GHRL protein inhibits the reaction [Nitroprusside results in increased expression of MAP3K5 protein]] | 17543279 |
| D020849 | Raloxifene Hydrochloride | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of MAP3K5 mRNA | 19059307 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species affects the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein] | 16449798 |
| C059514 | resveratrol | resveratrol results in increased activity of MAP3K5 protein | 15217905 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Streptozocin results in increased expression of MAP3K5 protein] | 26499206 |
| C059514 | resveratrol | MAP3K5 protein promotes the reaction [resveratrol results in increased activity of MAPK8 protein] | 15217905 |
| C059514 | resveratrol | MAP3K5 protein promotes the reaction [resveratrol results in increased expression of FASLG] | 15217905 |
| C059514 | resveratrol | MAP3K5 protein results in increased susceptibility to resveratrol | 15217905 |
| D012402 | Rotenone | Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] | 16449798 |
| D012402 | Rotenone | Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein] | 16449798 |
| C496827 | salubrinal | salubrinal affects the susceptibility to MAP3K5 protein | 20929985 |
| C496827 | salubrinal | salubrinal affects the susceptibility to [Paraquat co-treated with MAP3K5 protein] | 20929985 |
| C496827 | salubrinal | salubrinal inhibits the reaction [MAP3K5 protein affects the localization of CYCS protein] | 20929985 |
| C496827 | salubrinal | salubrinal inhibits the reaction [MAP3K5 protein results in increased activity of CASP3 protein] | 20929985 |
| C496827 | salubrinal | salubrinal inhibits the reaction [Paraquat results in increased phosphorylation of and results in increased activity of MAP3K5 protein] | 19735704 |
| C496827 | salubrinal | salubrinal promotes the reaction [MAP3K5 protein results in increased degradation of SQSTM1 protein] | 20929985 |
| C496827 | salubrinal | salubrinal promotes the reaction [MAP3K5 protein results in increased expression of BECN1 protein] | 20929985 |
| C496827 | salubrinal | salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein] | 20929985 |
| C496827 | salubrinal | salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased expression of BECN1 protein] | 20929985 |
| D012643 | Selenium | Selenium results in decreased expression of MAP3K5 mRNA | 19244175 |
| C009250 | sevoflurane | sevoflurane results in increased phosphorylation of MAP3K5 protein | 18349187 |
| C017947 | sodium arsenite | sodium arsenite results in increased activity of MAP3K5 protein | 16337887 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of MAP3K5 mRNA | 22714537 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of MAP3K5 mRNA | 22155349 |
| C016104 | sodium bichromate | sodium bichromate results in increased expression of MAP3K5 mRNA | 22155349 |
| D018038 | Sodium Selenite | Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein] | 26522834 |
| D013311 | Streptozocin | Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein] | 26522834 |
| D013311 | Streptozocin | [Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein | 26522834 |
| D013311 | Streptozocin | Streptozocin promotes the reaction [MAP3K5 protein results in increased expression of SERPINE1 protein] | 16731828 |
| D013311 | Streptozocin | resveratrol inhibits the reaction [Streptozocin results in increased expression of MAP3K5 protein] | 26499206 |
| D013311 | Streptozocin | Streptozocin results in increased expression of MAP3K5 protein | 26499206 |
| D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAP3K5 mRNA | 21641980 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K5 mRNA | 26378955 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MAP3K5 mRNA | 19059307 |
| D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MAP3K5 mRNA | 19619570 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of MAP3K5 mRNA | 22574217 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of MAP3K5 mRNA | 19619570 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in decreased expression of MAP3K5 mRNA | 25975270 |
| D013750 | Tetrachloroethylene | Tetrachloroethylene results in increased expression of MAP3K5 mRNA | 28973375 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of MAP3K5 mRNA | 25613284 |
| D013853 | Thioacetamide | Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein] | 12370186 |
| D013853 | Thioacetamide | Thioacetamide results in increased activity of MAP3K5 protein | 12370186 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of MAP3K5 mRNA | 23411599 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of MAP3K5 mRNA | 23557971 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of MAP3K5 mRNA | 28111298 |
| D014212 | Tretinoin | Tretinoin results in increased expression of MAP3K5 mRNA | 21934132|2372400 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of MAP3K5 mRNA | 22498432 |
| C012589 | trichostatin A | trichostatin A results in increased expression of MAP3K5 mRNA | 24935251 |
| C057693 | troglitazone | mito-carboxy proxyl inhibits the reaction [troglitazone results in increased activity of MAP3K5 protein] | 17975114 |
| C057693 | troglitazone | troglitazone results in increased activity of MAP3K5 protein | 17975114 |
| C005865 | troxerutin | "troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAP3K5 protein]" | 25639565 |
| D014415 | Tunicamycin | Tunicamycin results in increased phosphorylation of and results in increased activity of MAP3K5 protein | 19735704 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of MAP3K5 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of MAP3K5 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of MAP3K5 mRNA | 17292431 |
| D014752 | Vinyl Chloride | Vinyl Chloride results in decreased expression of MAP3K5 mRNA | 18579281 |
| D014810 | Vitamin E | Vitamin E results in decreased expression of MAP3K5 mRNA | 19244175 |